|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
CTG004880250 |
| 003 |
DE-627 |
| 005 |
20210519002409.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
210507s2021 xx |||||o 00| ||und c |
| 035 |
|
|
|a (DE-627)CTG004880250
|
| 035 |
|
|
|a (DE-599)UBBS_Klinische_Studien_WHODRKS00021238
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)DRKS00021238
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)2020-001408-41
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)203/20 (FF-MC)
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a und
|
| 082 |
0 |
|
|a 610
|
| 245 |
1 |
0 |
|a A prospective, randomized, double blinded placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia
|b A prospective, randomized, double blinded placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia - TOC-COVID
|
| 264 |
|
1 |
|c 2021
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), Registered on 22/04/2020, Last updated on 2021-04-29
|
| 773 |
0 |
8 |
|i Enthalten in
|t WHO International Clinical Trials Registry Platform
|g (2021) vom: 05. Jan.
|
| 773 |
1 |
8 |
|g year:2021
|g day:05
|g month:01
|
| 856 |
4 |
0 |
|u http://www.drks.de/DRKS00021238
|z kostenfrei
|3 Volltext
|
| 912 |
|
|
|a GBV_CTG
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|j 2021
|b 05
|c 01
|
| 953 |
|
|
|2 045F
|a 610
|
Klinische Studie